What is Sebivo?
Sebivo is an antiviral medication prescribed for the treatment of chronic hepatitis B virus (HBV) infection. It belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors. Sebivo helps to decrease the amount of HBV in the body. This action can improve liver function and reduce liver damage caused by the infection. It is specifically the L-isomer of thymidine, a natural component of DNA. This drug is intended for adult patients who show signs of active viral replication and inflammation of the liver.
How does Sebivo work?
Sebivo works by directly interfering with the lifecycle of the hepatitis B virus. The active ingredient, Telbivudine, inhibits the HBV DNA polymerase enzyme. This enzyme is crucial for the virus to replicate its genetic material and multiply. By blocking this process, Sebivo effectively reduces the viral load (the amount of virus) in the bloodstream. This reduction in viral activity helps to lessen the strain on the liver. Over time, this can lead to decreased liver inflammation and a lower risk of long-term complications like cirrhosis or liver cancer.
Who is Sebivo for?
Sebivo is for adults diagnosed with chronic hepatitis B who have active viral replication. This is usually determined through blood tests that show the presence of the virus and elevated liver enzymes. It is suitable for patients whose liver is still showing signs of damage or inflammation due to the ongoing infection. Sebivo is not a cure for hepatitis B. It is a treatment designed to manage the virus and prevent further progression of liver disease. Your doctor will perform tests to confirm that this medication is the right choice for your specific condition.
Dosage and administration
Sebivo is typically prescribed as a once-daily oral tablet. It can be taken with or without food, which offers flexibility for patients. The standard dose is the same for most adults, but it may be adjusted by a doctor for individuals with kidney problems. For the medication to be effective, you must take it consistently every day as directed by your healthcare provider. Skipping doses can reduce the drug’s effectiveness and may lead to the virus becoming resistant. Always follow your doctor’s instructions carefully and do not stop taking Sebivo without consulting them first, as this can cause a severe flare-up of the hepatitis B infection.
Side effects
Sebivo may cause some side effects, though not everyone will experience them. Common side effects are often mild and can include headache, fatigue, dizziness, nausea, and diarrhea. Some patients may also report a cough or rash. More serious side effects are rare but require immediate medical attention. These include muscle pain or weakness, a condition called lactic acidosis (a buildup of acid in the blood), and severe worsening of hepatitis B if you stop taking the drug. Your doctor will monitor you for these effects, especially when you first start treatment or if you discontinue it.
Why buy from IsraelPharm?
IsraelPharm is a trusted source for authentic, high-quality medications like Sebivo at competitive prices. We connect you with licensed pharmacies, ensuring you receive genuine products manufactured by leading pharmaceutical companies. Our streamlined ordering process makes getting your prescription simple and convenient. With a focus on customer safety and satisfaction, we provide discreet and reliable shipping directly to your door. Our knowledgeable customer service team is available to assist you with any questions about your order, helping you manage your health with confidence and ease.
Common side effects of Sebivo may include:
- Fatigue or feeling tired
- Headache
- Dizziness
- Nausea and diarrhea
- Abdominal pain
- Rash
- Cough
In rare cases, more severe side effects can occur, such as:
- Lactic acidosis (buildup of acid in the blood)
- Severe liver problems, especially after stopping the medication
- Muscle pain, tenderness, or weakness (myopathy)
Sebivo is indicated for the treatment of chronic hepatitis B in adult patients who show:
- Evidence of active viral replication.
- Persistent elevations in serum aminotransferases (ALT or AST).
- Evidence of histologically active liver disease.